Ratings by Stifel (Annabel Samimy)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/5/2026 | Regenxbio Inc. | RGNX | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2026 | Oculis Holding AG | OCS | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2026 | Ligand Pharma | LGND | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2026 | Phathom Pharmaceuticals | PHAT | Maintain | Buy (N/A) |
|
Details | ||
| 1/28/2026 | Regenxbio Inc. | RGNX | Maintain | Buy (N/A) |
|
Details | ||
| 1/15/2026 | Phathom Pharmaceuticals | PHAT | Maintain | Buy (Buy) |
|
Details | ||
| 1/13/2026 | MBX Biosciences Inc | MBX | Maintain | Buy (Buy) |
|
Details | ||
| 1/13/2026 | Evolus | EOLS | Maintain | Buy (Buy) |
|
Details | ||
| 12/19/2025 | Trevi Therapeutics | TRVI | Maintain | Buy (Buy) |
|
Details | ||
| 12/19/2025 | Trevi Therapeutics | TRVI | Maintain | Buy (N/A) |
|
Details | ||
| 12/19/2025 | Supernus Pharmaceuticals | SUPN | Maintain | Hold (Hold) |
|
Details | ||
| 12/19/2025 | Regenxbio Inc. | RGNX | Maintain | Buy (Buy) |
|
Details | ||
| 12/19/2025 | Oculis Holding AG | OCS | Maintain | Buy (Buy) |
|
Details | ||
| 12/19/2025 | Mineralys Therapeutics, Inc. | MLYS | Maintain | Buy (Buy) |
|
Details | ||
| 12/19/2025 | MBX Biosciences Inc | MBX | Maintain | Buy (Buy) |
|
Details | ||
| 12/19/2025 | Apellis Pharmaceuticals | APLS | Maintain | Buy (Buy) |
|
Details | ||
| 12/9/2025 | Ligand Pharma | LGND | Maintain | Buy (N/A) |
|
Details | ||
| 12/8/2025 | Structure Therapeutics | GPCR | Maintain | Buy (N/A) |
|
Details | ||
| 12/2/2025 | Structure Therapeutics | GPCR | Maintain | Buy (Buy) |
|
Details | ||
| 11/6/2025 | Ligand Pharma | LGND | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2025 | Supernus Pharmaceuticals | SUPN | Maintain | Hold (N/A) |
|
Details | ||
| 10/3/2025 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (Buy) |
|
Details | ||
| 8/28/2025 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (Buy) |
|
Details | ||
| 8/22/2025 | Oculis Holding AG | OCS | Maintain | Buy (N/A) |
|
Details | ||
| 8/19/2025 | Regenxbio Inc. | RGNX | Maintain | Buy (Buy) |
|
Details | ||
| 8/6/2025 | Supernus Pharmaceuticals | SUPN | Maintain | Hold (N/A) |
|
Details | ||
| 8/6/2025 | Evolus | EOLS | Maintain | Buy (N/A) |
|
Details | ||
| 7/18/2025 | Clearside Biomedical | CLSD | Downgrade | Hold (Buy) |
0.84 (0.41) |
-51.19% | Details | |
| 7/17/2025 | Ligand Pharma | LGND | Maintain | Buy (Buy) |
|
Details | ||
| 6/24/2025 | MBX Biosciences Inc | MBX | Maintain | Buy (Buy) |
|
Details | ||
| 6/12/2025 | MBX Biosciences Inc | MBX | Maintain | Buy (Buy) |
|
Details | ||
| 6/11/2025 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (Buy) |
|
Details | ||
| 6/6/2025 | Phathom Pharmaceuticals | PHAT | Maintain | Buy (N/A) |
|
Details | ||
| 6/5/2025 | Regenxbio Inc. | RGNX | Maintain | Buy (N/A) |
|
Details | ||
| 6/3/2025 | Trevi Therapeutics | TRVI | Maintain | Buy (N/A) |
|
Details | ||
| 5/30/2025 | Evolus | EOLS | Maintain | Buy (Buy) |
|
Details | ||
| 5/20/2025 | Regenxbio Inc. | RGNX | Maintain | Buy (Buy) |
|
Details | ||
| 5/20/2025 | Trevi Therapeutics | TRVI | Maintain | Buy (Buy) |
|
Details | ||
| 5/15/2025 | Clearside Biomedical | CLSD | Maintain | Buy (Buy) |
|
Details | ||
| 5/13/2025 | Regenxbio Inc. | RGNX | Maintain | Buy (Buy) |
|
Details | ||
| 5/12/2025 | MBX Biosciences Inc | MBX | Maintain | Buy (N/A) |
|
Details | ||
| 4/23/2025 | Trevi Therapeutics | TRVI | Maintain | Buy (Buy) |
|
Details | ||
| 4/15/2025 | Oculis Holding AG | OCS | Maintain | Buy (N/A) |
|
Details | ||
| 4/10/2025 | Ligand Pharma | LGND | New Coverage | Buy (N/A) |
96.67 (201.90) |
108.85% | Details | |
| 4/1/2025 | Rani Therapeutics Holdsing s | RANI | Maintain | Buy (Buy) |
|
Details | ||
| 3/31/2025 | Mineralys Therapeutics, Inc. | MLYS | Maintain | Buy (Buy) |
|
Details | ||
| 3/28/2025 | Clearside Biomedical | CLSD | Maintain | Buy (Buy) |
|
Details | ||
| 3/27/2025 | Rani Therapeutics Holdsing s | RANI | Maintain | Hold (N/A) |
|
Details | ||
| 3/19/2025 | Trevi Therapeutics | TRVI | Maintain | Buy (Buy) |
|
Details | ||
| 3/14/2025 | Regenxbio Inc. | RGNX | Maintain | Buy (Buy) |
|
Details | ||
| 3/12/2025 | Oculis Holding AG | OCS | Maintain | Buy (Buy) |
|
Details | ||
| 3/10/2025 | Mineralys Therapeutics, Inc. | MLYS | Maintain | Buy (N/A) |
|
Details | ||
| 3/10/2025 | Trevi Therapeutics | TRVI | Maintain | Buy (N/A) |
|
Details | ||
| 3/6/2025 | Phathom Pharmaceuticals | PHAT | Maintain | Buy (N/A) |
|
Details | ||
| 3/5/2025 | Evolus | EOLS | Maintain | Buy (Buy) |
|
Details | ||
| 2/28/2025 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2025 | Mineralys Therapeutics, Inc. | MLYS | Maintain | Buy (Buy) |
|
Details | ||
| 2/20/2025 | Trevi Therapeutics | TRVI | Maintain | Buy (N/A) |
|
Details | ||
| 2/7/2025 | Phathom Pharmaceuticals | PHAT | Maintain | Buy (N/A) |
|
Details | ||
| 2/4/2025 | Supernus Pharmaceuticals | SUPN | Maintain | Hold (N/A) |
|
Details | ||
| 1/21/2025 | Evolus | EOLS | Maintain | Buy (N/A) |
|
Details | ||
| 1/8/2025 | Structure Therapeutics | GPCR | New Coverage | Buy (N/A) |
27.50 (57.73) |
109.93% | Details | |
| 1/6/2025 | Oculis Holding AG | OCS | Maintain | Buy (N/A) |
|
Details | ||
| 12/9/2024 | Revance Therapeutic | RVNC | Maintain | Hold (N/A) |
|
Details | ||
| 11/13/2024 | Kamada Ltd. | KMDA | Maintain | Buy (N/A) |
|
Details | ||
| 10/8/2024 | MBX Biosciences Inc | MBX | New Coverage | Buy (N/A) |
23.75 (30.55) |
28.63% | Details | |
| 9/20/2024 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 9/11/2024 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (Buy) |
|
Details | ||
| 8/14/2024 | Mineralys Therapeutics, Inc. | MLYS | Maintain | Buy (N/A) |
|
Details | ||
| 8/12/2024 | Revance Therapeutic | RVNC | Downgrade | Hold (Buy) |
3.53 (3.65) |
3.4% | Details | |
| 8/9/2024 | Revance Therapeutic | RVNC | Maintain | Buy (N/A) |
|
Details | ||
| 7/2/2024 | Kamada Ltd. | KMDA | New Coverage | Buy (N/A) |
4.83 (8.86) |
83.44% | Details | |
| 6/24/2024 | Rani Therapeutics Holdsing s | RANI | Maintain | Buy (N/A) |
|
Details | ||
| 6/24/2024 | Regenxbio Inc. | RGNX | Maintain | Buy (N/A) |
|
Details | ||
| 6/13/2024 | Cara Therapeutics | CARA | Downgrade | Hold (Buy) |
0.66 (5.32) |
706.06% | Details | |
| 5/28/2024 | Calliditas Therapeutics | CALT | Downgrade | Hold (Buy) |
22.42 (40.00) |
78.41% | Details | |
| 5/3/2024 | Phathom Pharmaceuticals | PHAT | New Coverage | Buy (N/A) |
9.26 (10.67) |
15.23% | Details | |
| 4/8/2024 | Supernus Pharmaceuticals | SUPN | Maintain | Hold (N/A) |
|
Details | ||
| 3/15/2024 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 3/8/2024 | Evolus | EOLS | Maintain | Buy (N/A) |
|
Details | ||
| 3/7/2024 | Regenxbio Inc. | RGNX | Maintain | Buy (N/A) |
|
Details | ||
| 1/12/2024 | Revance Therapeutic | RVNC | Maintain | Buy (N/A) |
|
Details | ||
| 1/11/2024 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 1/3/2024 | Evolus | EOLS | Maintain | Buy (N/A) |
|
Details | ||
| 11/2/2023 | Rani Therapeutics Holdsing s | RANI | Maintain | Buy (N/A) |
|
Details | ||
| 11/1/2023 | Regenxbio Inc. | RGNX | New Coverage | Buy (N/A) |
14.37 (8.65) |
-39.81% | Details | |
| 10/5/2023 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 10/4/2023 | Oculis Holding AG | OCS | New Coverage | Buy (N/A) |
11.34 (26.96) |
137.74% | Details | |
| 8/29/2023 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2023 | Cara Therapeutics | CARA | Maintain | Buy (N/A) |
|
Details | ||
| 7/31/2023 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 7/28/2023 | Reata Pharmaceuticals | RETA | Downgrade | Hold (Buy) |
108.55 (172.36) |
58.78% | Details | |
| 7/17/2023 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 6/26/2023 | FibroGen | FGEN | Downgrade | Hold (Buy) |
16.05 (9.71) |
-39.5% | Details | |
| 6/2/2023 | FibroGen | FGEN | Upgrade | Buy (Hold) |
17.25 (9.71) |
-43.71% | Details | |
| 5/5/2023 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 4/17/2023 | Prometheus Biosciences Inc | RXDX | Downgrade | Hold (Buy) |
112.86 (199.92) |
77.14% | Details | |
| 4/13/2023 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
| 3/7/2023 | Mineralys Therapeutics, Inc. | MLYS | New Coverage | Buy (N/A) |
19.14 (26.59) |
38.92% | Details | |
| 3/1/2023 | Iveric Bio | ISEE | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2023 | Revance Therapeutic | RVNC | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2023 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
| 2/21/2023 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 2/10/2023 | Evolus | EOLS | Maintain | Buy (N/A) |
|
Details | ||
| 1/4/2023 | Supernus Pharmaceuticals | SUPN | Maintain | Hold (N/A) |
|
Details | ||
| 1/4/2023 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 12/12/2022 | Horizon Therapeutics | HZNP | Downgrade | Hold (Buy) |
97.29 (116.30) |
19.54% | Details | |
| 12/12/2022 | Prometheus Biosciences Inc | RXDX | Maintain | Buy (N/A) |
|
Details | ||
| 12/7/2022 | Prometheus Biosciences Inc | RXDX | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2022 | Clearside Biomedical | CLSD | Upgrade | Buy (Hold) |
1.40 (0.84) |
-40% | Details | |
| 11/9/2022 | Supernus Pharmaceuticals | SUPN | Maintain | Hold (N/A) |
|
Details | ||
| 11/9/2022 | Revance Therapeutic | RVNC | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2022 | FibroGen | FGEN | Maintain | Hold (N/A) |
|
Details | ||
| 11/3/2022 | Bausch Health Companies | BHC | Maintain | Buy (N/A) |
|
Details | ||
| 11/2/2022 | Horizon Therapeutics | HZNP | Maintain | Buy (N/A) |
|
Details | ||
| 11/1/2022 | Prometheus Biosciences Inc | RXDX | Maintain | Buy (N/A) |
|
Details | ||
| 10/12/2022 | Evofem Biosciences Inc | EVFM | Downgrade | Hold (Buy) |
0.48 (0.01) |
-97.92% | Details | |
| 9/28/2022 | PhaseBio Pharmaceuticals Inc. | PHAS | Downgrade | Hold (Buy) |
0.76 (0.07) |
-90.79% | Details | |
| 9/26/2022 | Horizon Therapeutics | HZNP | Maintain | Buy (N/A) |
|
Details | ||
| 9/8/2022 | Revance Therapeutic | RVNC | Maintain | Buy (N/A) |
|
Details | ||
| 9/8/2022 | Iveric Bio | ISEE | Maintain | Buy (N/A) |
|
Details | ||
| 9/8/2022 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 9/6/2022 | Iveric Bio | ISEE | Maintain | Buy (N/A) |
|
Details | ||
| 8/23/2022 | Aerie Pharma | AERI | Downgrade | Hold (Buy) |
11.15 (15.25) |
36.77% | Details | |
| 8/12/2022 | Prometheus Biosciences Inc | RXDX | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2022 | Bausch Health Companies | BHC | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2022 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 8/3/2022 | Horizon Therapeutics | HZNP | Maintain | Buy (N/A) |
|
Details | ||
| 7/28/2022 | Bausch Health Companies | BHC | Maintain | Buy (N/A) |
|
Details | ||
| 6/30/2022 | Angion Biomedica | ANGN | Downgrade | Hold (Buy) |
1.82 (1.00) |
-45.05% | Details | |
| 6/28/2022 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 6/17/2022 | Apellis Pharmaceuticals | APLS | New Coverage | Buy (N/A) |
41.17 (20.07) |
-51.25% | Details | |
| 5/4/2022 | Iveric Bio | ISEE | Maintain | Buy (N/A) |
|
Details | ||
| 1/14/2022 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 1/14/2022 | Horizon Therapeutics | HZNP | Maintain | Buy (N/A) |
|
Details | ||
| 1/14/2022 | FibroGen | FGEN | Maintain | Hold (N/A) |
|
Details | ||
| 1/14/2022 | Evofem Biosciences Inc | EVFM | Maintain | Buy (N/A) |
|
Details | ||
| 1/14/2022 | Clearside Biomedical | CLSD | Maintain | Hold (N/A) |
|
Details | ||
| 1/14/2022 | Aerie Pharma | AERI | Maintain | Buy (N/A) |
|
Details | ||
| 12/16/2021 | Calliditas Therapeutics | CALT | Maintain | Buy (N/A) |
|
Details | ||
| 12/10/2021 | Angion Biomedica | ANGN | Maintain | Buy (Buy) |
|
Details | ||
| 12/9/2021 | Radius Health | RDUS | Maintain | Hold (N/A) |
|
Details | ||
| 12/9/2021 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
| 11/12/2021 | Prometheus Biosciences Inc | RXDX | New Coverage | Buy (N/A) |
37.00 (199.92) |
440.32% | Details | |
| 11/10/2021 | Revance Therapeutic | RVNC | Maintain | Buy (N/A) |
|
Details | ||
| 11/2/2021 | Evolus | EOLS | Maintain | Buy (N/A) |
|
Details | ||
| 10/27/2021 | Angion Biomedica | ANGN | Maintain | Buy (N/A) |
|
Details | ||
| 10/21/2021 | Revance Therapeutic | RVNC | Maintain | Buy (N/A) |
|
Details | ||
| 10/20/2021 | Radius Health | RDUS | Maintain | Hold (N/A) |
|
Details | ||
| 10/13/2021 | PhaseBio Pharmaceuticals Inc. | PHAS | New Coverage | Buy (N/A) |
3.85 (0.07) |
-98.18% | Details | |
| 9/10/2021 | Iveric Bio | ISEE | New Coverage | Buy (N/A) |
8.79 (39.95) |
354.49% | Details | |
| 8/24/2021 | Rani Therapeutics Holdsing s | RANI | New Coverage | Buy (N/A) |
16.04 (1.30) |
-91.9% | Details | |
| 8/12/2021 | Evofem Biosciences Inc | EVFM | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2021 | Radius Health | RDUS | Maintain | Hold (N/A) |
|
Details | ||
| 8/4/2021 | Horizon Therapeutics | HZNP | Maintain | Buy (N/A) |
|
Details | ||
| 7/16/2021 | FibroGen | FGEN | Downgrade | Hold (Buy) |
24.84 (9.71) |
-60.91% | Details | |
| 6/22/2021 | Calliditas Therapeutics | CALT | Maintain | Buy (N/A) |
|
Details | ||
| 5/24/2021 | Strongbridge Biopharma | SBBP | Maintain | Buy (N/A) |
|
Details | ||
| 5/11/2021 | Cara Therapeutics | CARA | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2021 | TherapeuticsMD | TXMD | Maintain | Buy (N/A) |
|
Details | ||
| 4/14/2021 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 4/7/2021 | FibroGen | FGEN | Maintain | Buy (N/A) |
|
Details | ||
| 3/17/2021 | Horizon Therapeutics | HZNP | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2021 | TherapeuticsMD | TXMD | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2021 | Angion Biomedica | ANGN | New Coverage | Buy (N/A) |
17.34 (1.00) |
-94.23% | Details | |
| 2/24/2021 | Bausch Health Companies | BHC | Maintain | Buy (N/A) |
|
Details | ||
| 2/23/2021 | Revance Therapeutic | RVNC | Maintain | Buy (N/A) |
|
Details | ||
| 2/19/2021 | Evolus | EOLS | Maintain | Buy (N/A) |
|
Details | ||
| 2/18/2021 | Calliditas Therapeutics | CALT | Maintain | Buy (N/A) |
|
Details | ||
| 12/17/2020 | Horizon Therapeutics | HZNP | Maintain | Buy (N/A) |
|
Details | ||
| 12/17/2020 | Evolus | EOLS | Maintain | Buy (N/A) |
|
Details | ||
| 12/14/2020 | FibroGen | FGEN | Maintain | Buy (N/A) |
|
Details | ||
| 11/25/2020 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2020 | Calliditas Therapeutics | CALT | Maintain | Buy (N/A) |
|
Details | ||
| 11/2/2020 | Horizon Therapeutics | HZNP | Maintain | Buy (N/A) |
|
Details | ||
| 10/23/2020 | FibroGen | FGEN | Maintain | Buy (N/A) |
|
Details | ||
| 10/2/2020 | Evofem Biosciences Inc | EVFM | New Coverage | Buy (N/A) |
2.36 (0.48) |
-79.66% | Details | |
| 8/10/2020 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
| 8/7/2020 | TherapeuticsMD | TXMD | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2020 | Horizon Therapeutics | HZNP | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2020 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2020 | Mallinckrodt plc | MNK | Maintain | Hold (N/A) |
|
Details | ||
| 7/31/2020 | Horizon Therapeutics | HZNP | Maintain | Buy (N/A) |
|
Details | ||
| 7/17/2020 | Aerie Pharma | AERI | Maintain | Buy (N/A) |
|
Details | ||
| 7/13/2020 | Trevi Therapeutics | TRVI | Maintain | Buy (N/A) |
|
Details | ||
| 7/10/2020 | Reata Pharmaceuticals | RETA | New Coverage | Buy (N/A) |
158.00 (172.36) |
9.09% | Details | |
| 7/10/2020 | FibroGen | FGEN | New Coverage | Buy (N/A) |
41.91 (9.71) |
-76.83% | Details | |
| 7/7/2020 | Evolus | EOLS | Maintain | Buy (N/A) |
|
Details | ||
| 6/8/2020 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 5/29/2020 | Horizon Therapeutics | HZNP | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2020 | Trevi Therapeutics | TRVI | Maintain | Buy (N/A) |
|
Details | ||
| 5/7/2020 | TherapeuticsMD | TXMD | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2020 | Horizon Therapeutics | HZNP | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2020 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 4/24/2020 | Radius Health | RDUS | New Coverage | Hold (N/A) |
15.75 (30.00) |
90.48% | Details | |
| 4/8/2020 | Horizon Therapeutics | HZNP | Maintain | Buy (N/A) |
|
Details | ||
| 4/1/2020 | Aerie Pharma | AERI | Maintain | Buy (N/A) |
|
Details | ||
| 3/27/2020 | TherapeuticsMD | TXMD | Maintain | Buy (N/A) |
|
Details | ||
| 3/16/2020 | Mallinckrodt plc | MNK | Maintain | Hold (N/A) |
|
Details | ||
| 2/11/2020 | Allergen | AGN | Maintain | Hold (N/A) |
|
Details | ||
| 1/10/2020 | Trevi Therapeutics | TRVI | Maintain | Buy (N/A) |
|
Details | ||
| 1/10/2020 | TherapeuticsMD | TXMD | Maintain | Buy (N/A) |
|
Details | ||
| 1/10/2020 | Supernus Pharmaceuticals | SUPN | Maintain | Hold (N/A) |
|
Details | ||
| 1/10/2020 | Revance Therapeutic | RVNC | Maintain | Buy (N/A) |
|
Details | ||
| 1/10/2020 | Clearside Biomedical | CLSD | Maintain | Hold (N/A) |
|
Details | ||
| 12/16/2019 | Horizon Pharma | HZNP | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2019 | Strongbridge Biopharma | SBBP | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2019 | Revance Therapeutic | RVNC | Maintain | Buy (N/A) |
|
Details | ||
| 10/25/2019 | TherapeuticsMD | TXMD | Maintain | Buy (N/A) |
|
Details | ||
| 9/13/2019 | Horizon Pharma | HZNP | Maintain | Buy (N/A) |
|
Details | ||
| 9/10/2019 | Mallinckrodt plc | MNK | Maintain | Hold (N/A) |
|
Details | ||
| 9/9/2019 | Mallinckrodt plc | MNk | Maintain | Hold (N/A) |
|
Details | ||
| 8/8/2019 | Supernus Pharmaceuticals | SUPN | Maintain | Buy (N/A) |
|
Details | ||
| 8/7/2019 | Supernus Pharmaceuticals | SUPN | Maintain | Buy (N/A) |
|
Details | ||
| 8/7/2019 | Mallinckrodt plc | MNK | Maintain | Hold (N/A) |
|
Details | ||
| 7/31/2019 | Evolus | EOLS | Maintain | Buy (N/A) |
|
Details | ||
| 6/3/2019 | Trevi Therapeutics | TRVI | New Coverage | Buy (N/A) |
9.11 (13.30) |
45.99% | Details | |
| 5/29/2019 | Cara Therapeutics | CARA | Maintain | Buy (N/A) |
|
Details | ||
| 5/29/2019 | Cara Therapeutics | CARA | Maintain | Buy (Buy) |
|
Details | ||
| 5/21/2019 | Mallinckrodt plc | MNK | Maintain | Hold (N/A) |
|
Details | ||
| 5/7/2019 | Allergen | AGN | Maintain | Hold (N/A) |
|
Details | ||
| 4/9/2019 | Evolus | EOLS | Maintain | Buy (N/A) |
|
Details | ||
| 1/29/2019 | Evolus | EOLS | New Coverage | Buy (N/A) |
14.91 (5.53) |
-62.91% | Details | |
| 1/29/2019 | Revance Therapeutic | RVNC | New Coverage | Buy (N/A) |
17.27 (3.53) |
-79.56% | Details | |
| 11/5/2018 | Clearside Biomedical | CLSD | Downgrade | Hold (Buy) |
5.56 (1.40) |
-74.82% | Details | |
| 11/1/2018 | Horizon Pharma | HZNP | Maintain | Buy (N/A) |
|
Details | ||
| 10/17/2018 | Allergen | AGN | Maintain | Hold (N/A) |
|
Details | ||
| 9/17/2018 | Allergen | AGN | Maintain | Buy (N/A) |
|
Details |
